Last $11.32 USD
Change Today 0.00 / 0.00%
Volume 669.1K
MNTA On Other Exchanges
Symbol
Exchange
NASDAQ GS
Frankfurt
As of 8:10 PM 07/23/14 All times are local (Market data is delayed by at least 15 minutes).

Executive Profile*

Craig A. Wheeler

Chief Executive Officer, President and Executive Director, Momenta Pharmaceuticals Inc.
AgeTotal Calculated CompensationThis person is connected to 81 board members in 4 different organizations across 4 different industries.

See Board Relationships
54$2,858,949
As of Fiscal Year 2013

Background*

Mr. Craig A. Wheeler has been the Chief Executive Officer of Momenta Pharmaceuticals Inc., since September 12, 2006 and has been its President since August 22, 2006. Mr. Wheeler serves as the Treasurer and Secretary of Generic Pharmaceutical Association. He has extensive professional experience in the biotechnology and healthcare industries. Mr. Wheeler served as a Vice President of Chiron Corp. from August 2001 to June 2006. He served as the President of Chiron Biopharmaceuticals, ...

Read Full Background

Corporate Headquarters*

675 West Kendall Street
Cambridge, Massachusetts 02142

United States

Phone: 617-491-9700
Fax: 617-621-0431

Board Members Memberships*

Director
Treasurer, Secretary and Director
2005-Present
Chairman, Chairman of Executive Committee, Chairman of Corporate Governance Committee and Member of Audit Committee
2006-Present
Chief Executive Officer, President and Executive Director

Education*

MS
Cornell University
BS
Cornell University
MBA
University of Pennsylvania - The Wharton School

Other Affiliations*

Annual Compensation*

Salary$621,000
Total Annual Compensation$621,000

Stock Options*

Restricted Stock Awards$754,800
All Other Compensation$29,229
Exercisable Options808,250
Exercisable Options Value$2,889,165
Unexercisable Options243,750
Unexercisable Options Value$963,125
Total Value of Options$3,852,290
Total Number of Options1,052,000

Total Compensation*

Total Annual Cash Compensation$1,022,829
Total Short Term Compensation$621,000
Other Long Term Compensation$784,029
Total Calculated Compensation$2,858,949
*Data is at least as current as the most recent Definitive Proxy.
 

Stock Quotes

Market data is delayed at least 15 minutes.

Company Lookup
Recently Viewed
MNTA:US $11.32 USD 0.00

COMPETITOR COMPENSATION

NamePosition/
Company
Compensation
Ted William Karkus Chairman and Chief Executive Officer
ProPhase Labs, Inc.
$775.0K
Douglas A. Michels Chief Executive Officer, President and Director
OraSure Technologies, Inc.
$563.4K
Peter S. Greenleaf Chief Executive Officer, Director, Member of Commercialization Committee and Member of Science & Technology Committee
Sucampo Pharmaceuticals, Inc.
--
Scott L. Tarriff Chief Executive Officer, President and Director
Eagle Pharmaceuticals Inc.
$408.0K
Venkaiah Chowdary Nannapaneni M. Pharm M SChairman, Managing Director, Chairman of Allotment Committee, Member of Audit Committee, Member of Compensation Committee and Member of Investor Grievance Committee
Natco Pharma Limited
--
Compensation as of Fiscal Year 2013.

Sponsored Financial Commentaries

Sponsored Links

Report Data Issue

To contact MOMENTA PHARMACEUTICALS INC, please visit . Company data is provided by Capital IQ. Please use this form to report any data issues.

Please enter your information in the following field(s):
Update Needed*

All data changes require verification from public sources. Please include the correct value or values and a source where we can verify.

Your requested update has been submitted

Our data partners will research the update request and update the information on this page if necessary. Research and follow-up could take several weeks. If you have questions, you can contact them at bwwebmaster@businessweek.com.